A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.

@article{Lindsay2017APE,
  title={A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.},
  author={Colin R Lindsay and Vincent Faugeroux and Stefan Michiels and Evane Pailler and Francesco Facchinetti and Dayi Ou and Mar{\'i}a Virginia Bluthgen and Chloe Pannet and Maud Ngo-Camus and Guillaume Bescher and Caroline Caramella and Fanny Billiot and J Hern{\'a}ndez Rem{\'o}n and David C. Planchard and J-C Soria and Benjamin Besse and Françoise Farace},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2017},
  volume={28 7},
  pages={
          1523-1531
        }
}
Background We report the first study examining the clinical, numerical and biological properties of circulating tumor cells according to molecular subtypes of non-small-cell lung cancer. Patients and methods 125 patients with treatment-naïve stage IIIb-IV NSCLC were prospectively recruited for CellSearch analysis. Anti-vimentin antibody was included for examination of CTCs to assess their mesenchymal character. Associations of total CTCs and vimentin-positive (vim +) CTCs with clinical… CONTINUE READING
BETA
27
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress

  • Computational and structural biotechnology journal
  • 2018
VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: a report from the PETRUS prospective study

C Massard, M Oulhen, S Le Moulec
  • Oncotarget 2016 [Epub ahead of print]
  • 2016

Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine.

  • Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • 2014

Similar Papers

Loading similar papers…